Cheap Off-the-Shelf Cell Culture Mixes Could Slash Serum Costs for Cultivated Meat

Foetal bovine serum, the amber liquid harvested from bovine fetuses at slaughterhouses, has propped up animal cell culture for three-quarters of a century. It is also one of the most expensive, ethically fraught and chemically unpredictable ingredients in biotechnology. Now researchers at University College London have shown that a systematic, low-cost trawl through commercial serum-free products already sitting on laboratory shelves can uncover formulations that match serum-containing media while cutting volumetric cost by a third, a finding with direct implications for cultivated meat, regenerative medicine and industrial cell cultivation at large.

The study, published in the journal 3 Biotech by Matthew A. J. Wasmuth and Darren N. Nesbeth of the Department of Biochemical Engineering, took an approach the authors describe as a repurposing screen, a strategy borrowed from drug discovery where existing molecules are tested for functions far removed from their intended use. Rather than accepting the manufacturer’s label on each serum-free product, which typically markets it for biopharmaceutical production or regenerative medicine, the team evaluated fifteen commercial products purely on how well they supported cell growth and how much they cost per litre. The logic is straightforward: the metabolic requirements of a mammalian cell are dictated by cellular physiology, not by marketing categories, so products optimised for one application may quietly outperform in another.

From the fifteen products, which included six base media, four serum alternatives and five complete serum-free formulations, the researchers assembled twenty-nine different media mixes, each assigned an arbitrary letter code. These were tested against the gold standard of the field, Dulbecco’s Modified Eagle Medium supplemented with twenty percent foetal bovine serum, using the murine Sol8 myoblast cell line. Myoblasts are the progenitors of muscle fibres and can mature into multinucleated myotube networks, making them a relevant model for both basic muscle biology and the emerging cultivated meat sector, where muscle and fat cells are the raw material of the final product.

The screening design was deliberately austere. Cells grown in serum-containing medium were transferred in a single step, with no adaptation period, into two-millilitre wells of each test mix, and viable cell numbers were counted at days three and six. A binary pass-or-fail criterion, did cell numbers increase or not, allowed all twenty-nine mixes to be evaluated for roughly the same cost as running ten mixes with triplicate replication. The authors argue this mirrors the commercial reality of emerging sectors, where finite budgets force a trade-off between the breadth of conditions tested and the statistical rigour applied to each. Twenty of the mixes reduced or failed to increase cell numbers; nine supported growth.

Combining the growth data with per-litre cost figures produced a two-dimensional cost-performance map that proved decisive. Thirteen mixes caused cell numbers to plummet by seventy to one hundred percent of the seeded population, while several complete media products marketed for specific applications, including AIM-V and M199, performed dismally. Only four mixes cost more per litre than the serum-containing benchmark, and none of those outperformed it. Among the seven growth-supporting mixes that undercut the benchmark on price, one stood out: Mix D, a combination of Fisher’s base medium with two percent by volume of Ultroser G, a serum alternative. Mix D supported the highest level of cell growth in the shortlist while costing thirty-three percent less per litre than twenty percent foetal bovine serum DMEM.

Follow-up experiments probed the economics and metabolism of Mix D in detail. Ultroser G accounts for ninety-four percent of the mix’s ninety-seven pounds eighty-four pence per litre price tag, so the team tested whether cutting its concentration would preserve performance. Reducing it by a quarter or a half would have dropped the cost to roughly seventy-five or fifty-two pounds per litre respectively, but growth fell off sharply, indicating the supplement’s constituents are critical at their standard level. Metabolite analysis with a CuBiAn bioanalyser revealed a striking asymmetry: the serum-containing medium contained four times more glucose than Mix D, yet cells in both media consumed similar amounts of glucose per cell. Most intriguingly, cells in Mix D produced approximately tenfold less lactate per cell than their serum-grown counterparts at nearly every time point over a twelve-day cultivation.

Lactate accumulation is a persistent headache in industrial cell culture because it acidifies the medium, forcing more frequent media changes or extra buffering capacity, both of which inflate operating costs. The authors suggest the low-glucose Mix D leaves headroom for cheap carbon-source supplementation within a broader multi-factor optimisation framework, and they flag the reduced lactate burden as a potentially valuable process-level benefit, particularly for cultivated meat, where objectives around biomass accumulation and differentiation may demand different metabolic profiles from those optimised in traditional biopharmaceutical processes.

A key question for any new medium is whether apparent performance gains reflect genuine suitability or merely the emergence of a lucky subpopulation of cells that has adapted or been selected over successive passages. The researchers addressed this directly. Sol8 cells cultured for three passages in Mix D, designated Sol8_D, showed growth profiles indistinguishable from cells transferred in a single step, with no statistically significant difference in cell-specific growth rate. Four clonally derived subpopulations isolated by limiting dilution all matched the parental line’s performance. The authors interpret this as evidence that Mix D imposes no strong selection pressure and that its growth support reflects a uniformly complete trophic environment rather than stochastic adaptation, while noting that the failure of adaptation to boost growth further hints at an absolute nutritional limitation, possibly the absence of peptide or steroidal components present in foetal bovine serum.

Perhaps the most consequential result came from testing Mix D across species and lineages. The formulation supported growth of the porcine muscle cell line pMYOSC to the same endpoint as serum-containing medium, albeit with an initial dip over the first six days, and matched serum performance for the porcine adipose-derived stem cell line pADSC for nine days before falling roughly fifty percent short at the endpoint. The murine pre-adipocyte line 3T3 L1 grew comparably for six days before trailing. Critically, 3T3 L1 cells adapted to Mix D retained their capacity to differentiate into adipocytes, the fat cells essential to the flavour and texture of cultivated meat, as confirmed by Oil Red-O lipid staining after transfer to adipogenic differentiation medium. Cross-species compatibility matters because species-specific media development at industrial scale is cost-prohibitive, and a single formulation supporting muscle and fat lineages could enable co-culture strategies that reduce vessel numbers, medium preparation complexity and contamination risk.

The authors are candid about limitations. The screen ran at single replicate, so false negatives among the twenty rejected mixes cannot be excluded, and the proprietary composition of the commercial products constrains mechanistic interpretation. They recommend metabolomic, proteomic and lipidomic profiling of fresh and spent media as a route to reverse-engineer the functional components, and suggest that direct commercial partnerships, incentivised by the prospect of high-volume food-grade orders, could unlock formulation disclosure. They also highlight three sub-fifty-pounds-per-litre mixes, I, A and L, that supported measurable growth and merit future characterisation. Set against estimates that growth media account for fifty-five to ninety-nine percent of cultivated meat production costs, with serum itself consuming sixty to eighty percent of media expenditure, the demonstration that a thirty-percent cost reduction is achievable with an off-the-shelf product, using only inexpensive equipment, offers a pragmatic roadmap. As the authors conclude, such low-cost, evidence-driven approaches are likely to play an important role as the cultivated meat industry weathers the inevitable cycles of capital investment that lie ahead.

Subject of Research: Serum-free media repurposing screening for cost-effective industrial animal cell cultivation

Article Title: A repurposing screen of 29 media mixtures derived from 15 commercial serum-free media products identifies potential cost reductions for industrial animal cell cultivation

Article References: Wasmuth, M. A. J., & Nesbeth, D. N. (2026). A repurposing screen of 29 media mixtures derived from 15 commercial serum-free media products identifies potential cost reductions for industrial animal cell cultivation. 3 Biotech, 16(11), Article 468. https://doi.org/10.1007/s13205-026-05091-5

Image Credits: AI Generated

DOI: 10.1007/s13205-026-05091-5

Keywords: cell culture, serum-free media, foetal bovine serum, cultivated meat, media repurposing, Sol8 myoblasts, Ultroser G, bioprocess economics, adipocyte differentiation, porcine cell lines, cost reduction, biomanufacturing